Aureus Asset Management, LLC Vertex Pharmaceuticals Inc Transaction History

Aureus Asset Management, LLC

$1.51 Billion
Q3 2024

A detailed history of Aureus Asset Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Aureus Asset Management, LLC holds 2,186 shares of VRTX stock, worth $1.03 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

2,186

Previous 2,266 3.53%

Holding current value

$1.03 Million

Previous $1.06 Million 4.33%

% of portfolio

0.07%

Previous 0.07%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$460.0 - $505.78 $36,800 - $40,462	-80 Reduced 3.53%	2,186 $1.02 Million
Q4 2023 Feb 14, 2024	SELL	$343.0 - $410.68 $13,720 - $16,427	-40 Reduced 1.73%	2,266 $922,000
Q2 2023 Aug 11, 2023	SELL	$314.42 - $351.91 $24,210 - $27,097	-77 Reduced 3.23%	2,306 $811,000
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $10,953 - $12,221	-40 Reduced 1.65%	2,383 $690,000
Q1 2021 May 14, 2021	SELL	$207.02 - $241.31 $28,982 - $33,783	-140 Reduced 5.46%	2,423 $521,000
Q4 2020 Feb 16, 2021	SELL	$207.01 - $276.09 $422,300 - $563,223	-2,040 Reduced 44.32%	2,563 $606,000
Q2 2020 Aug 11, 2020	BUY	$225.48 - $295.8 $31,567 - $41,412	140 Added 3.14%	4,603 $1.34 Million
Q1 2020 May 14, 2020	SELL	$199.77 - $247.81 $29,366 - $36,428	-147 Reduced 3.19%	4,463 $1.06 Million
Q4 2019 Feb 12, 2020	SELL	$166.71 - $223.91 $40,010 - $53,738	-240 Reduced 4.95%	4,610 $1.01 Million
Q3 2019 Nov 12, 2019	SELL	$166.23 - $187.09 $17,620 - $19,831	-106 Reduced 2.14%	4,850 $822,000
Q2 2019 Aug 14, 2019	SELL	$164.61 - $190.37 $56,625 - $65,487	-344 Reduced 6.49%	4,956 $909,000
Q1 2019 May 13, 2019	SELL	$163.73 - $194.7 $24,559 - $29,205	-150 Reduced 2.75%	5,300 $975,000
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $16,773 - $19,274	-100 Reduced 1.8%	5,450 $1.05 Million
Q2 2018 Aug 13, 2018	BUY	$145.72 - $169.96 $349,728 - $407,904	2,400 Added 76.19%	5,550 $943,000
Q1 2018 May 15, 2018	BUY	$151.6 - $177.13 $7,580 - $8,856	50 Added 1.61%	3,150 $513,000
Q3 2017 Nov 13, 2017	BUY	$148.13 - $162.24 $459,203 - $502,944	3,100	3,100 $471,000

Others Institutions Holding VRTX

# of Institutions

1,725

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aureus Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aureus Asset Management, LLC with notifications on news.

Account

Aureus Asset Management, LLC Vertex Pharmaceuticals Inc Transaction History